Clinical trial Recruiting at 1 site Observational Ages 18 and up

French validation of the SAHOT outcome tool after subarachnoid hemorrhage

Official title: Validation of the French Version of the Subarachnoid Haemorrhage Outcome Tool (SAHOT): a Prospective Single-Centre Cohort Study

Run by Fondation Ophtalmologique Adolphe de Rothschild · NCT07894666 · Data updated 2026-11-12

This study tests whether a French version of the SAHOT questionnaire reliably measures outcomes in adults after subarachnoid hemorrhage.

More Subarachnoid Hemorrhage trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment70 (estimated)
SponsorFondation Ophtalmologique Adolphe de Rothschild
Research network
Locations1 site (Paris)
StatusRecruiting
StartedSeptember 28, 2026
Main results expectedOctober 1, 2028
Study endsNovember 1, 2028
Registry record updatedOctober 26, 2026
Trial IDNCT07894666 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults over 18 with a subarachnoid hemorrhage of any cause, assessed within 12 months of the event, seen at the Rothschild hospital, and able to complete the questionnaire (or with a guardian/relative who can participate in proxy form).

Probably not a fit

Patients who do not speak French, or who have an active psychiatric disorder that prevents questionnaire completion, may not benefit from this validation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective, single-centre observational study will validate the French translation of the SAHOT, a patient-reported outcome measure for subarachnoid hemorrhage. Adults seen for follow-up within 12 months of SAH will complete the self-administered French SAHOT, with a proxy version available for accompanying relatives. The primary goal is to assess internal consistency of the French SAHOT; seventy participants are planned, with relatives helping complete proxy assessments when appropriate. The study excludes non-French speakers and individuals with psychiatric conditions that preclude questionnaire completion. The Fondation Ophtalmologique Adolphe de Rothschild sponsors the effort, conducted at Hôpital Fondation Adolphe de Rothschild in Paris.

Why it matters

Potential benefit: If successful, the French SAHOT could provide clinicians with a reliable tool to capture cognitive, psychological, physical, and social outcomes after SAH in French-speaking patients.

How similar studies have gone: SAHOT has been developed and validated in English; this is a French-language validation effort to extend its applicability, with prior success in the English-speaking setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria (patients):

* Age over 18 years
* Subarachnoid haemorrhage of any aetiology
* Onset less than 12 months before inclusion
* Seen in consultation at the Hôpital Fondation Adolphe de Rothschild
* Judged able to complete a self-administered questionnaire by the evaluating clinician
* Informed and not opposed to participation (or relative's non-opposition if the patient is under guardianship and/or unable to consent)

Inclusion Criteria (relatives):

* Age over 18 years
* Relative / caregiver of a patient with subarachnoid haemorrhage within the previous 12 months
* Attending the follow-up consultation of an included patient
* Informed and not opposed to participation

Exclusion Criteria (patients and relatives):

* Non-French-speaking
* Psychiatric disorder judged incompatible with completion of the questionnaires by the investigator

Where it's running

  • Hôpital Fondation Adolphe de Rothschild
    Paris, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.